MARYANN LUKOWICH: Open Payments
NPI 1538305545 · COCHRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 45 payments from 17 companies in 2025. Trend: 2023 $804 · 2024 $716 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $149 |
| PFIZER INC. | 5 | $92 |
| Boston Scientific Corporation | 1 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Verona Pharma, Inc. | 3 | $69 |
| Novo Nordisk Inc | 4 | $64 |
| Lilly USA, LLC | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
Products named: WATCHMAN FLX, VRAYLAR, ELIQUIS, Ohtuvayre, MOUNJARO, TRELEGY ELLIPTA, QULIPTA, REXULTI.
Industry payments across PA — which companies pay providers there.
